Award recordCONTRACT

GENZYME CORPORATION

PIID VA25515F5111· VHA· 255-NETWORK CONTRACT OFFICE 15· 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS· FY2015· $150,854 net obligations· UEI X2XMAQLR9DA8· MA

Description

ALEMTUZUMAB 12MG/1.2ML INJ VIAL (LEMTRADA) NDC 58468-0200-01

First action · last action
2015-09-11 · 2015-09-11
Transactions
1
First transaction's obligation
$150,854
Base + all options value (sum of deltas)
$150,854
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797P2086D
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 1 transaction

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$150,854$0Base award · 2015-09-11 · this action $150,854 · running total $150,854
  • Base2015-09-11+$150,854= $150,854
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2015-09-11+$150,854$150,854ALEMTUZUMAB 12MG/1.2ML INJ VIAL (LEMTRADA) NDC 58468-0200-01

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI X2XMAQLR9DA8)

AwardOffice · PSC / listingNet obligationsFY
36E79724A0018NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C26124N0260261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$11,882FY2024
36C26023F0186260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$144,553FY2023
36C26223F0045262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$246,001FY2023
36C26223F0022262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$266,652FY2023
36C26222F0606262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$20,049FY2022

Other recipients under 6550 from 255-NETWORK CONTRACT OFFICE 15 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA25513F4651FISHER SCIENTIFIC COMPANY L.L.C.255-NETWORK CONTRACT OFFICE 15$10,554FY2013
VA25513F1573ABBOTT LABORATORIES INC.255-NETWORK CONTRACT OFFICE 15$4,709FY2013
VA25513J0587HANGER, INC.255-NETWORK CONTRACT OFFICE 15$5,218FY2013
VA25513F0273BAXTER HEALTHCARE CORPORATION255-NETWORK CONTRACT OFFICE 15$10,260FY2013
VA25512P2304FEDERAL LOGISTICS GROUP INC255-NETWORK CONTRACT OFFICE 15$13,802FY2012

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25515F5111_3600_V797P2086D_3600 · retrieved 2026-09-26.